VBI Vaccines

$0.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0287 (-4.42%) Today
$0.00 (0.00%) As of 4:50 PM EDT after-hours

Why Robinhood?

You can buy or sell VBI Vaccines and other stocks, options, ETFs, and crypto commission-free!

About VBIV

VBI Vaccines, Inc. New Common Stock (Canada), also called VBI Vaccines, is a biopharmaceutical company, which engages in the development of vaccines for infectious disease and immuno-oncology. Read More Its pipeline include HBV Therapeutic,HBV Prophylaxis, CMV Propylaxis, GBM Immunotherapy, MB Immunotherapy, and Zika Propylaxis. The company was founded on July 9, 2015 is headquartered in Cambridge, MA.

Employees
112
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
60.61M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
447.48K
High Today
$0.68
Low Today
$0.5965
Open Price
$0.68
Volume
490.06K
52 Week High
$2.78
52 Week Low
$0.575

Collections

VBIV Earnings

-$0.28
-$0.23
-$0.18
-$0.13
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.22 per share
Actual
-$0.13 per share

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.